Preview

Tuberculosis and Lung Diseases

Advanced search

INVESTIGATION OF SENSITIVITY TO ANTIFUNGAL AGENTS IN ASPERGILLUS FUNGICAUSING BRONCHIAL PULMONARY IN FECTION IN TUBERCULOSIS PATIENTS

https://doi.org/10.21292/2075-1230-2017-95-7-54-60

Abstract

The sensitivity levels of 12 fungal species of Aspergillus, identified when diagnosing pneumonomycosis in tuberculosis patients, to 10 antifungal agents were identified and analyzed. The sensitivity of 202 strains of Aspergillus spp. to antifungal agents was tested by microdilution methods defining minimal inhibitory concentrations in μg/ml (Sensititre system). It was found out that agents causing aspergillosis differed in the level of their resistance to the medication of amphotericin B. Three species with poor sensitivity to this medication were identified: A. terreus (possesses natural resistance to amphotericin B), and A. flavus and A. ochraceus (it is reasonable to test sensitivity to amphotericin B prior to the treatment start). Voriconazolum, intraconazolum and pozaconazolum were found to be active against Aspergillus spp. fungi, but for certain strains of A. ustus (the fungus with poor sensitivity to medications of the azolum group, the sensitivity to be tested prior to the start of treatment) as well as some strains of A. nidulans and A. niger. The article describes a modified method for preparation of Aspergillus spp. spore suspension enhancing safety of sensitivity testing and reliability of the results.

About the Author

A. B. Kulko
Moscow Municipal Scientific Practical Center of Tuberculosis Control, Health Department of Moscow
Russian Federation

Aleksandr B. Kulko - Candidate of Biological Sciences, Researcher of Department of Laboratory Diagnostics of Tuberculosis and Pathomorphology.

10, Stromynka St., Moscow, 107014 Phone: +7 (499) 268-70-33


References

1. Groll A.H., Walsh T.D. Aspergilez. Altas gribkovykh zabolevany. [Aspergillosis. Atlas of fungal diseases]. Ed. by K.A. Kaufman, D.L. Mandell. Moscow, GEOTAR-Media Publ., 2010, pp. 133-159.

2. D.R. Hospenthal, M.G. Rinaldi. Diagnostika i lecheniye mikozov. (Russ. Ed.: D.R. Hospenthal, M.G. Rinaldi. Diagnosis and Treatment of Human Mycoses). Moscow, GEOTAR-Media Publ., 2013, 448 p.

3. Elinov N.P., Mitrofanov V.S., Chernopyatova R.M. Aspergilleous infection: approaches to its diagnostic and treatment. Probl. Meditsinskoy Mikologii, 2002, vol. 4, no. 1, pp. 4-8. (In Russ.)

4. Klimko N.N. Mikozy: diagnostika i lechenie. Rukovodstvo dlya vrachey. [Mycoses: diagnostics and treatment. Doctors' Manual]. 2nd Edition, Moscow, V G Group Publ., 2008, 336 p.

5. Kulko A.B. Аtlas uslovno-patogennykh gribov roda Aspergillus – vozbuditeley bronkholegochnykh infektsiy. [Atlas of opportunistic fungi of Aspergillus species – causative agents of bronchial and pulmonary infection]. Moscow, MNPTSBT Publ., 2012, 160 p.

6. Kulko А.B., Dreval P.А., Vorobiev А.А., Trusov V.N. Laboratory diagnostics of bronchopulmonary aspergillosis in tuberculosis patients with cavities in the lungs. Probl. Meditsinskoy Mikologii, 2008, vol.10, no. 4, pp. 25-28. (In Russ.)

7. Lovacheva O.V., Kornienko I.I., Kulko А.B., Slogotskaya L.V., Litvinov V.I. Treatment of itraconazololum suspension of opportunistic fungal colonization of the respiratory tract in pulmonary tuberculosis patients. Probl. Tuberkuleza i Bolezni Legkikh, 2008, no. 1, pp. 42-46. (In Russ.)

8. Marfenina O.E. Аntropogennaya ekologiya pochvennykh gribov. [Anthropogenic ecology of soil fungi]. Moscow, Meditsina Dlya Vsekh Publ., 2005, 196 p.

9. Sutton D., Fothergill A., Rinaldi M. Opredelitel patogennykh i uslovno patogennykh gribov. (Russ. ed.: Sutton D., Fothergill A., Rinaldi M., Determinant of pathogenic and opportunistic fungi.) Moscow, Mir Publ., 2001, 468 p.

10. Sergeev А.Yu., Sergeev Yu.V. Gribkovye infektsii. Rukovodstvo dlya vrachey. [Fungal infections. Doctors' guidelines]. Moscow, Binom Publ., 2008, 480 p.

11. Clinical and Laboratory Standards Institute (CLSI). Reference method for broth dilution antifungal susceptibility testing of filamentous fungi; approved standard – Second edition. SLCI document M38-A2. CLSI: Wayne, PA., 2008, 40 p.

12. EUCAST Definitive Document E.DEF 9.1: Method for the determination of broth dilution minimum inhibitory concentrations of antifungal agents for conidia forming moulds Subcommittee on Antifungal Susceptibility Testing (AFST) of the ESCMID European Committee for Antimicrobial Susceptibility Testing (EUCAST), 2008. 13 p.

13. European Committee on Antimicrobial Susceptibility Testing. Antifungal Agents Breakpoint tables for interpretation of MICs. Version 8.0, valid from 2015-11-16, 2015.

14. Hoog de G.S., Guarro J., Gene J., Figueras M.J. Atlas of clinical fungi. Electronic Version 3.1 – CBS: Reus, 2011.

15. Latge J-P. Aspergillus fumigatus and Aspergillosis. Clin. Microbiol. Rev., 1999, vol. 12, no. 2, pp. 310-350.

16. Samson R.A., Hoekstra E.S., Frisvad J.C. Introduction to Food- and Airborne Fungi, ed. 7. Utrecht, Netherlands, CBS. 2004, 389 p.

17. The Aspergillus Website http://www.aspergillus.org.uk/

18. TREK Diagnostics Systems http://www.trekds.com/techinfo/default.asp


Review

For citations:


Kulko A.B. INVESTIGATION OF SENSITIVITY TO ANTIFUNGAL AGENTS IN ASPERGILLUS FUNGICAUSING BRONCHIAL PULMONARY IN FECTION IN TUBERCULOSIS PATIENTS. Tuberculosis and Lung Diseases. 2017;95(7):54-60. (In Russ.) https://doi.org/10.21292/2075-1230-2017-95-7-54-60

Views: 1396


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 2075-1230 (Print)
ISSN 2542-1506 (Online)